Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 378

1.

Randomised clinical trial: transabdominal interferential electrical stimulation vs sham stimulation in women with functional constipation.

Moore JS, Gibson PR, Burgell RE.

Aliment Pharmacol Ther. 2020 Mar 3. doi: 10.1111/apt.15642. [Epub ahead of print]

PMID:
32128859
2.

Initial experiences of an in-reach service providing iron infusions in residential aged care facilities.

Zinsaz H, Calder G, Corallo C, Gibson PR, Poojary S, Moran C.

Australas J Ageing. 2020 Feb 23. doi: 10.1111/ajag.12776. [Epub ahead of print]

PMID:
32090443
3.

Dietary Guidance for Patients With Inflammatory Bowel Disease from the International Organization for the Study of Inflammatory Bowel Disease.

Levine A, Rhodes JM, Lindsay JO, Abreu MT, Kamm MA, Gibson PR, Gasche C, Silverberg MS, Mahadevan U, Sigall BR, Wine E, Damas OM, Syme G, Trakman GL, Yao CK, Stockhamer S, Hammami MB, Garces LC, Rogler G, Koutroubakis IE, Ananthakrishnan A, McKeever L, Lewis JD.

Clin Gastroenterol Hepatol. 2020 Feb 15. pii: S1542-3565(20)30185-3. doi: 10.1016/j.cgh.2020.01.046. [Epub ahead of print] Review.

PMID:
32068150
4.

The Potential of Integrated Nurse-Led Models to Improve Care for People With Functional Gastrointestinal Disorders: A Systematic Review.

Linedale EC, Mikocka-Walus A, Gibson PR, Andrews JM.

Gastroenterol Nurs. 2020 Jan/Feb;43(1):53-64. doi: 10.1097/SGA.0000000000000379.

PMID:
31990873
5.

Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease.

Gibson DJ, Ward MG, Rentsch C, Friedman AB, Taylor KM, Sparrow MP, Gibson PR.

Aliment Pharmacol Ther. 2020 Mar;51(6):612-628. doi: 10.1111/apt.15643. Epub 2020 Jan 21. Review.

PMID:
31961001
6.

Editorial: inaccuracies in attribution of symptoms due to gluten-not just in those with self-reported noncoeliac gluten sensitivity.

Gibson PR.

Aliment Pharmacol Ther. 2020 Feb;51(3):402-403. doi: 10.1111/apt.15620. No abstract available.

PMID:
31943272
7.

Chronic constipation and abdominal pain: Independent or closely interrelated symptoms?

Wong MYW, Hebbard G, Gibson PR, Burgell RE.

J Gastroenterol Hepatol. 2020 Jan 3. doi: 10.1111/jgh.14970. [Epub ahead of print] Review.

PMID:
31900961
8.

Commentary: recognising the boom in coeliac disease prevalence was more than just increased awareness.

Gibson PR.

Aliment Pharmacol Ther. 2020 Jan;51(1):207-208. doi: 10.1111/apt.15552. No abstract available.

PMID:
31850552
9.

Histologic Healing Is More Strongly Associated with Clinical Outcomes in Ileal Crohn's Disease than Endoscopic Healing.

Christensen B, Erlich J, Gibson PR, Turner JR, Hart J, Rubin DT.

Clin Gastroenterol Hepatol. 2019 Dec 5. pii: S1542-3565(19)31396-5. doi: 10.1016/j.cgh.2019.11.056. [Epub ahead of print]

PMID:
31812654
10.

Study design of endoscopic polypectomy on clopidogrel (EPOC): A randomised controlled trial.

Ket S, Metz A, Moss A, Ogra R, Tam W, Secomb R, Reynolds J, Gibson PR, Brown G.

Contemp Clin Trials Commun. 2019 Nov 1;16:100479. doi: 10.1016/j.conctc.2019.100479. eCollection 2019 Dec.

11.

Successful elevation of circulating acetate and propionate by dietary modulation does not alter T-regulatory cell or cytokine profiles in healthy humans: a pilot study.

Gill PA, van Zelm MC, Ffrench RA, Muir JG, Gibson PR.

Eur J Nutr. 2019 Oct 24. doi: 10.1007/s00394-019-02113-2. [Epub ahead of print]

PMID:
31650328
12.

Systematic review: Clinical utility of gastrointestinal ultrasound in the diagnosis, assessment and management of patients with ulcerative colitis.

Smith RL, Taylor KM, Friedman AB, Gibson RN, Gibson PR.

J Crohns Colitis. 2019 Sep 28. pii: jjz163. doi: 10.1093/ecco-jcc/jjz163. [Epub ahead of print]

PMID:
31562739
13.

Intestinal gases: influence on gut disorders and the role of dietary manipulations.

Kalantar-Zadeh K, Berean KJ, Burgell RE, Muir JG, Gibson PR.

Nat Rev Gastroenterol Hepatol. 2019 Dec;16(12):733-747. doi: 10.1038/s41575-019-0193-z. Epub 2019 Sep 13. Review.

PMID:
31520080
14.

Dietary fat and the faecal microbiome: where collinearity may lead to incorrect attribution of effects to fat.

Ardalan ZS, Sparrow MP, Muir JG, Gibson PR.

Gut. 2019 Sep 6. pii: gutjnl-2019-319628. doi: 10.1136/gutjnl-2019-319628. [Epub ahead of print] No abstract available.

PMID:
31492690
15.

Clinical coding data algorithm to categorize type of gastrointestinal bleeding as a primary reason for massive transfusion: results from the Australian and New Zealand Massive Transfusion Registry.

Ket SN, Sparrow RL, McQuilten ZK, Tacey M, Gibson PR, Brown GJ, Wood EM.

Vox Sang. 2019 Nov;114(8):853-860. doi: 10.1111/vox.12840. Epub 2019 Sep 6.

PMID:
31489645
16.

Review article: the role of the autonomic nervous system in the pathogenesis and therapy of IBD.

Mogilevski T, Burgell R, Aziz Q, Gibson PR.

Aliment Pharmacol Ther. 2019 Oct;50(7):720-737. doi: 10.1111/apt.15433. Epub 2019 Aug 16. Review.

PMID:
31418887
17.

Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target?

Garg M, Royce SG, Tikellis C, Shallue C, Batu D, Velkoska E, Burrell LM, Patel SK, Beswick L, Jackson A, Britto K, Lukies M, Sluka P, Wardan H, Hirokawa Y, Tan CW, Faux M, Burgess AW, Hosking P, Monagle S, Thomas M, Gibson PR, Lubel J.

Gut. 2019 Aug 13. pii: gutjnl-2019-318512. doi: 10.1136/gutjnl-2019-318512. [Epub ahead of print]

PMID:
31409604
18.

Will Science Sway Beliefs About Gluten?

Halmos EP, Gibson PR.

Gastroenterology. 2019 Sep;157(3):607-609. doi: 10.1053/j.gastro.2019.06.024. Epub 2019 Jun 21. No abstract available.

PMID:
31233735
19.

Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.

Julsgaard M, Hvas CL, Gearry RB, Gibson PR, Fallingborg J, Sparrow MP, Bibby BM, Connell WR, Brown SJ, Kamm MA, Lawrance IC, Vestergaard T, Svenningsen L, Baekdal M, Kammerlander H, Walsh A, Boysen T, Bampton P, Radford-Smith G, Kjeldsen J, Andrews JM, Subramaniam K, Moore GT, Jensen NM, Connor SJ, Wildt S, Wilson B, Ellard K, Christensen LA, Bell SJ.

Inflamm Bowel Dis. 2020 Jan 1;26(1):93-102. doi: 10.1093/ibd/izz110.

PMID:
31141607
20.

Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis.

Little RD, Chu IE, van der Zanden EP, Flanagan E, Bell SJ, Gibson PR, Sparrow MP, Shelton E, Connor SJ, Roblin X, Ward MG.

J Crohns Colitis. 2019 Dec 10;13(12):1527-1536. doi: 10.1093/ecco-jcc/jjz103.

PMID:
31094417
21.

Controversies and reality of the FODMAP diet for patients with irritable bowel syndrome.

Halmos EP, Gibson PR.

J Gastroenterol Hepatol. 2019 Jul;34(7):1134-1142. doi: 10.1111/jgh.14650. Epub 2019 Apr 4. Review.

PMID:
30945376
22.

Letters: low FODMAP diet-directions for future research and the low FODMAP diet is not the only diet for IBS-authors' reply.

Mitchell H, Porter J, Gibson PR, Barrett J, Garg M.

Aliment Pharmacol Ther. 2019 Apr;49(8):1109-1110. doi: 10.1111/apt.15199. No abstract available.

PMID:
30920052
23.

The intestinal vitamin D receptor in inflammatory bowel disease: inverse correlation with inflammation but no relationship with circulating vitamin D status.

Garg M, Royce SG, Tikellis C, Shallue C, Sluka P, Wardan H, Hosking P, Monagle S, Thomas M, Lubel JS, Gibson PR.

Therap Adv Gastroenterol. 2019 Jan 18;12:1756284818822566. doi: 10.1177/1756284818822566. eCollection 2019.

24.

Systematic Review: Cost-effective Strategies of Optimizing Anti-tumor Necrosis and Immunomodulators in Inflammatory Bowel Disease.

Vasudevan A, Gibson PR, Van Langenberg DR.

Inflamm Bowel Dis. 2019 Aug 20;25(9):1462-1473. doi: 10.1093/ibd/izy399.

PMID:
30689858
25.

Reply.

Colombel JF, Shin A, Gibson PR.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):573-574. doi: 10.1016/j.cgh.2018.08.073. No abstract available.

PMID:
30678842
26.

Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems.

Ajamian M, Steer D, Rosella G, Gibson PR.

PLoS One. 2019 Jan 14;14(1):e0210728. doi: 10.1371/journal.pone.0210728. eCollection 2019.

27.

Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome-directions for future research.

Mitchell H, Porter J, Gibson PR, Barrett J, Garg M.

Aliment Pharmacol Ther. 2019 Jan;49(2):124-139. doi: 10.1111/apt.15079. Review.

PMID:
30589971
28.

Higher Mucosal Healing with Tumor Necrosis Factor Inhibitors in Combination with Thiopurines Compared to Methotrexate in Crohn's Disease.

Vasudevan A, Raghunath A, Anthony S, Scanlon C, Sparrow MP, Gibson PR, van Langenberg DR.

Dig Dis Sci. 2019 Jun;64(6):1622-1631. doi: 10.1007/s10620-018-5422-8. Epub 2018 Dec 17.

PMID:
30560332
29.

Prebiotics Versus Low FODMAP Diet: An Interpretative Nightmare.

Varney J, Muir JG, Gibson PR.

Gastroenterology. 2019 Mar;156(4):1222. doi: 10.1053/j.gastro.2018.10.060. Epub 2018 Dec 10. No abstract available.

PMID:
30543795
30.

Letter: vedolizumab drug concentrations in neonates following intrauterine exposure.

Flanagan E, Gibson PR, Begun J, Ghaly S, Garg M, Andrews JM, Rosella O, Rosella G, Bell SJ.

Aliment Pharmacol Ther. 2018 Dec;48(11-12):1328-1330. doi: 10.1111/apt.15027. No abstract available.

PMID:
30488628
31.

Review article: emulsifiers in the food supply and implications for gastrointestinal disease.

Halmos EP, Mack A, Gibson PR.

Aliment Pharmacol Ther. 2019 Jan;49(1):41-50. doi: 10.1111/apt.15045. Epub 2018 Nov 28. Review.

PMID:
30484878
32.

Characterization of ulcerative colitis-associated constipation syndrome (proximal constipation).

James SL, van Langenberg DR, Taylor KM, Gibson PR.

JGH Open. 2018 Aug 5;2(5):217-222. doi: 10.1002/jgh3.12076. eCollection 2018 Oct.

33.

Postpolypectomy prophylactic clip closure for the prevention of delayed postpolypectomy bleeding: A systematic review.

Mangira D, Ket SN, Majeed A, Gibson PR, Brown G.

JGH Open. 2018 Mar 25;2(3):105-110. doi: 10.1002/jgh3.12047. eCollection 2018 Jun. Review.

34.
35.

Referrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disorders.

Linedale EC, Shahzad MA, Kellie AR, Mikocka-Walus A, Gibson PR, Andrews JM.

JGH Open. 2017 Oct 31;1(3):84-91. doi: 10.1002/jgh3.12015. eCollection 2017 Nov.

36.

A Protocol-Driven Assessment Promotes a More Accurate Diagnosis of Irritable Bowel Syndrome.

Moore JS, Gibson PR, Perry RE, Burgell RE.

Gastroenterol Nurs. 2018 Nov/Dec;41(6):508-515. doi: 10.1097/SGA.0000000000000349.

PMID:
30418343
37.

Gluten-free and low-FODMAP sourdoughs for patients with coeliac disease and irritable bowel syndrome: A clinical perspective.

Muir JG, Varney JE, Ajamian M, Gibson PR.

Int J Food Microbiol. 2019 Feb 2;290:237-246. doi: 10.1016/j.ijfoodmicro.2018.10.016. Epub 2018 Oct 24.

PMID:
30388591
38.

Randomised clinical trial: reducing the intake of dietary FODMAPs of breastfeeding mothers is associated with a greater improvement of the symptoms of infantile colic than for a typical diet.

Iacovou M, Craig SS, Yelland GW, Barrett JS, Gibson PR, Muir JG.

Aliment Pharmacol Ther. 2018 Nov;48(10):1061-1073. doi: 10.1111/apt.15007. Epub 2018 Oct 10.

PMID:
30306603
39.

Efficacy of glutamine in postinfection IBS.

Ford AC, Gibson PR.

Gut. 2019 Oct;68(10):1905-1906. doi: 10.1136/gutjnl-2018-317438. Epub 2018 Sep 22. No abstract available.

PMID:
30244201
40.

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review.

Colombel JF, Shin A, Gibson PR.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):380-390.e1. doi: 10.1016/j.cgh.2018.08.001. Epub 2018 Aug 9. Review.

41.

Culture- and metagenomics-enabled analyses of the Methanosphaera genus reveals their monophyletic origin and differentiation according to genome size.

Hoedt EC, Parks DH, Volmer JG, Rosewarne CP, Denman SE, McSweeney CS, Muir JG, Gibson PR, Cuív PÓ, Hugenholtz P, Tyson GW, Morrison M.

ISME J. 2018 Dec;12(12):2942-2953. doi: 10.1038/s41396-018-0225-7. Epub 2018 Aug 1.

42.

The safety and sensitivity of a telemetric capsule to monitor gastrointestinal hydrogen production in vivo in healthy subjects: a pilot trial comparison to concurrent breath analysis.

Berean KJ, Ha N, Ou JZ, Chrimes AF, Grando D, Yao CK, Muir JG, Ward SA, Burgell RE, Gibson PR, Kalantar-Zadeh K.

Aliment Pharmacol Ther. 2018 Sep;48(6):646-654. doi: 10.1111/apt.14923. Epub 2018 Aug 1.

43.

Continuous Clinical Response Is Associated With a Change of Disease Course in Patients With Moderate to Severe Ulcerative Colitis Treated With Golimumab.

Reinisch W, Colombel JF, Gibson PR, Rutgeerts P, Sandborn WJ, Tarabar D, Huyck S, Khalifa A, Marano C, Philip G, Yao R, Zhang H, Cornillie F.

Inflamm Bowel Dis. 2019 Jan 1;25(1):163-171. doi: 10.1093/ibd/izy229.

PMID:
29982631
44.

Long-Term Benefit of Golimumab for Patients with Moderately to Severely Active Ulcerative Colitis: Results from the PURSUIT-Maintenance Extension.

Reinisch W, Gibson PR, Sandborn WJ, Feagan BG, Strauss R, Johanns J, Padgett L, Adedokun OJ, Colombel JF, Collins J, Rutgeerts P, Tarabar D, Marano C.

J Crohns Colitis. 2018 Aug 29;12(9):1053-1066. doi: 10.1093/ecco-jcc/jjy079.

PMID:
29917070
45.

Reply.

Skodje GI, Henriksen C, Veierød MB, Gibson PR, Lundin KEA.

Gastroenterology. 2018 Jul;155(1):228. doi: 10.1053/j.gastro.2018.06.032. Epub 2018 Jun 9. No abstract available.

PMID:
29894682
46.

Is Non-Celiac Rice-Starch Sensitivity as Common in Children as Non-Celiac Gluten Sensitivity?

Gibson PR, Lundin KEA, Guandalini S.

Am J Gastroenterol. 2018 Aug;113(8):1254. doi: 10.1038/s41395-018-0079-7. Epub 2018 Jun 8. No abstract available.

PMID:
29880973
47.

Illuminating dark depths.

Gibson PR, Burgell RE.

Science. 2018 May 25;360(6391):856-857. doi: 10.1126/science.aat8658. No abstract available.

PMID:
29798870
48.

Safety and Efficacy of Combination Treatment With Calcineurin Inhibitors and Vedolizumab in Patients With Refractory Inflammatory Bowel Disease.

Christensen B, Gibson PR, Micic D, Colman RJ, Goeppinger SR, Kassim O, Yarur A, Weber CR, Cohen RD, Rubin DT.

Clin Gastroenterol Hepatol. 2019 Feb;17(3):486-493. doi: 10.1016/j.cgh.2018.04.060. Epub 2018 May 8.

49.

Review article: short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders.

Gill PA, van Zelm MC, Muir JG, Gibson PR.

Aliment Pharmacol Ther. 2018 Jul;48(1):15-34. doi: 10.1111/apt.14689. Epub 2018 May 3. Review.

50.

Letter: vedolizumab for autoimmune liver disease associated inflammatory bowel disease-Authors' reply.

Christensen B, Gibson PR, Rubin DT.

Aliment Pharmacol Ther. 2018 May;47(10):1423-1424. doi: 10.1111/apt.14638. No abstract available.

Supplemental Content

Loading ...
Support Center